This is a working research document from the mental health filing, published as written — including the parts later corrected. It is the underlying record for Whitepaper No. 11, not a summary of it.
Date: 2026-08-11 Model: claude-opus-5 via the Anthropic Message Batches API (scripts/batch-rescore.py, batch msgbatch_013vUDQ6mt6JV8mz2H95zfsx). Blinding: structural. The scorer received one tool-less request containing the scoring brief (ws09-blind-brief-2026-08-11.md), the anchored scale (00-scales.md), and the evidence packet below inlined as text. It had no filesystem access and no search, so it could not reach ws09-scorecard.md, ws09-red-team-log.md, or deviations-log.md by any route.
Reconciled in: ws09-rescore-log.md. What follows after the packet manifest is the scorer's output, verbatim and unedited.
Packet manifest
Evidence was inlined from /private/tmp/gubment-batch-rescore-gbmt11-12/mental-health/ (batch working directory). Evidence files are not re-copied into git — they match the committed workstreams/phase0 on origin/main (SHA-256 checked at reconcile). Brief + raw scores are the research artifacts.
| Path in packet |
Bytes |
Repo counterpart |
BRIEF.md |
3784 |
ws09-blind-brief-2026-08-11.md |
SCORES.md |
25266 |
this file (body below) |
evidence/00-scales.md |
4126 |
packet-only extract of scorecard anchors (not a separate repo file) |
evidence/phase0-findings.md |
12108 |
mental-health/docs/phase0-findings.md |
evidence/ws01-baseline.md |
8335 |
mental-health/research/ws01-baseline.md |
evidence/ws02-licensed-available.md |
8460 |
mental-health/research/ws02-licensed-available.md |
evidence/ws03-imd-acute.md |
9561 |
mental-health/research/ws03-imd-acute.md |
evidence/ws04-crisis-988.md |
5970 |
mental-health/research/ws04-crisis-988.md |
evidence/ws05-medicaid-rates.md |
7914 |
mental-health/research/ws05-medicaid-rates.md |
evidence/ws06-parity.md |
8812 |
mental-health/research/ws06-parity.md |
evidence/ws07-precedents.md |
14126 |
mental-health/research/ws07-precedents.md |
evidence/ws08-political-economy-seam.md |
10394 |
mental-health/research/ws08-political-economy-seam.md |
What the scorer did not receive: ws09-scorecard.md, ws09-red-team-log.md, deviations-log.md, any site/mental-health/*, and this reconciliation log.
Evidence SHA note: At reconcile (2026-08-11), every evidence/ws0*.md and phase0-findings.md byte-matched the corresponding files on this branch (origin/main tip). 00-scales.md is the authored abstract scale shipped in the brief packet (aligned with the scorecard's O1–O5 anchors, including the symmetric evidence floor already baked into pass 1).
GBMT-11 Mental Health — blind re-score
1. The matrix
|
O1_realized_access |
O2_acute_crisis_capacity |
O3_workforce_takes_payer |
O4_financial_protection_parity |
O5_state_capacity_federalism |
| a1_medicaid_rate_floor |
3 |
3 |
4 |
3 |
4 |
| a2_ccbhc_expansion |
4 |
3 |
4 |
3 |
4 |
| a3_imd_repeal_waiver |
3 |
3 |
3 |
3 |
4 |
| a4_bed_rebuild |
3 |
3 |
3 |
3 |
4 |
| a5_crisis_continuum |
4 |
4 |
3 |
3 |
4 |
| a6_parity_erisa |
3 |
3 |
3 |
4 |
3 |
| a7_aot_expansion |
3 |
4 |
3 |
3 |
4 |
| a8_collaborative_care |
3 |
3 |
3 |
3 |
3 |
| a9_workforce_liberalization |
2 |
3 |
2 |
3 |
3 |
| a10_do_nothing |
3 |
2 |
2 |
2 |
4 |
Cell IDs below: rows a1–a10 = 1–10, columns O1–O5 = A–E.
2. Cell-by-cell basis
a1 — Medicaid rate floor + administrative simplification
| Cell |
Score |
Basis |
Flag |
| 1A |
3 |
ws05: Allegheny MCO rate-change design finds elasticity ≈0.16 (20% rate rise → ~3.2% more services) but "mostly to existing patients rather than new panel openings"; Zhu Health Affairs 2022 cross-section null (state Medicaid-to-Medicare indices uncorrelated with participating-psychiatrist supply); Decker null on reported participation. No wait/appointment-access outcome measured for any rate change. Real evidence both directions, none of it on appointment access. |
evidenced-wash |
| 1B |
3 |
Nothing in the record links Medicaid outpatient rate/prior-auth changes to boarding, bed supply, or crisis throughput. |
unevidenced-neutral |
| 1C |
4 |
ws05: Allegheny within-market staggered code-level rate increases → detectable increase in service quantity (O3 anchor 4 names "service quantity"); H5 adjudicated Supported ("rates and paperwork bind; elasticities modest"); Cunningham/CMS MMRR — rates + payment delay + billing requirements co-cited by physicians limiting Medicaid; NACHC same-day-billing bans as binding. Countervailing nulls (Zhu cross-section, Decker) keep this off 5. |
judgment-call (anchor's "service quantity" wording is doing the work; the instrument's own stated goal — panels opening — is not evidenced) |
| 1D |
3 |
No OOP/parity finding for Medicaid rate policy in the record. |
unevidenced-neutral |
| 1E |
4 |
ws05: state Medicaid FFS fee schedules for a common psychiatrist basket exist and are measurable in every state (indices 0.46 PA → 2.34 NE); an MCO in Allegheny actually executed staggered rate changes across many codes. The relevant agency level demonstrably runs rate-setting at scale. Admin-simplification half is less demonstrated (same-day billing bans persist). |
evidenced |
a2 — CCBHC expansion
| Cell |
Score |
Basis |
Flag |
| 2A |
4 |
ws05/anchor 9 (ASPE/Mathematica §223 evaluation): adult mean time to initial evaluation 9.0 → 5.4 days DY1→DY2; clients served +~9% across seven states (PA +23%); 94% of CCBHCs report open-access/same-day. Not 5: clinic-reported, pre/post without comparison group, and DY1→DY4 flattens (within-10-days stable ~69–73%; mean 9.1 → 8.4 days). |
evidenced |
| 2B |
3 |
ws05: claims DID heterogeneous — PA −13% BH-related ED visit count (no change in any-ED probability), MO +5.7% BH ambulatory visits, "hospitalizations/ED often null"; ws05 states explicitly this is "state-heterogeneous, not a uniform national win." I honoured the record's own mixed characterization rather than picking the PA positive. |
evidenced-wash |
| 2C |
4 |
ws05: PPS + certification package associated with more clients served (304,988 → 332,135 across reporting states) and near-universal open-access scheduling — a safety-net service-quantity/capacity response under Medicaid. |
evidenced |
| 2D |
3 |
No OOP or parity finding for CCBHCs in the record. |
unevidenced-neutral |
| 2E |
4 |
§223 demonstration operated by state Medicaid agencies with CMS across DY1–DY4 with measured delivery reporting (Mathematica/ASPE/RTC); >60 dual CHC–CCBHC certifications (NACHC). Held at 4 rather than 5 because GAO-21-104466 documents mixed spending effects and CMS guidance gaps on aligning PPS rates with costs / avoiding duplication — payment design is load-bearing and perishable. |
judgment-call (4 vs 5 was close on a literal reading of the O5 anchor) |
a3 — IMD repeal / broad MH IMD waiver
| Cell |
Score |
Basis |
Flag |
| 3A |
3 |
Nothing in the record on outpatient appointment or crisis access effects of IMD waivers. |
unevidenced-neutral |
| 3B |
3 |
ws03/ws07 both directions: (+) statute + CMS SMDL #18-011 + CRS IF10222 document that FFP for adult 21–64 IMD stays is barred by default, so the waiver directly changes admit-financing geography — a documented purchase constraint being relieved; (−) McBain et al. PLOS Medicine 2025 (HCRIS): MH IMD §1115 waiver states show no statistically significant higher psychiatric bed rates. ws03 explicitly says the null is "a caution for architecture scoring, not a full refute of the financing constraint" and "do not overclaim that waivers have already rebuilt Construct B supply." |
evidenced-wash |
| 3C |
3 |
No finding on payer-accepting clinicians. |
unevidenced-neutral |
| 3D |
3 |
No OOP/parity finding. |
unevidenced-neutral |
| 3E |
4 |
CRS IF10222 (as of 2025-01-14): ~15 states + DC with approved MH IMD §1115 authority plus a pending queue; CMS runs the SMI/SED opportunity. The waiver machinery is demonstrably operated at material scale by CMS + state Medicaid agencies. Note: the repeal half of this row requires Congress, and the record contains no evidence on statutory repeal capacity. |
evidenced |
a4 — Bed rebuild / state-hospital reinvestment
| Cell |
Score |
Basis |
Flag |
| 4A |
3 |
No record finding linking inpatient reinvestment to outpatient/crisis appointment access. |
unevidenced-neutral |
| 4B |
3 |
This is where the evidence floor bites hardest and I want it visible. The record documents need, not instrument effect: NRI 2025 (90% of responding states report inpatient psych bed shortage; forensic most cited), TAC 2023 Construct A ~36,150 / 10.8 per 100k with 52% forensic occupancy, McBain Construct B stable ~28.4/100k with STACH psych-unit share 24.9% → 20.6%, Pearlmutter multi-site boarding (admitted median 5.63h; Medicaid/uninsured >2× odds of ≥24h). Per discipline 2, problem size is not evidence of an instrument's effect, and no evaluation of a bed-rebuild or state-hospital reinvestment program appears in this base. The Australia low-bed/high-readmission pattern (ws07 counter-steelman) is a cross-national correlation, not an instrument evaluation. I did not dock this cell for H7's "wrong primary architecture" verdict, which is a ranking statement, not a within-cell failure finding. |
unevidenced-neutral (deliberate: I reasoned about the mechanism and refused to score it) |
| 4C |
3 |
No finding on payer-accepting clinicians or state-hospital staffing response to reinvestment (NRI reports shortages, not an instrument effect). |
unevidenced-neutral |
| 4D |
3 |
No OOP/parity finding. |
unevidenced-neutral |
| 4E |
4 |
State mental health agencies demonstrably operate state psychiatric hospitals at material scale with measured use reporting (NRI Use of State Psychiatric Hospitals, 2025 Profiles; 43/48 states responding; TAC staffed-bed censuses). Held at 4 not 5 because the instrument as specified is expansion/reinvestment, and the record contains no measured delivery of a capacity-expansion program. |
judgment-call |
a5 — 988 + mobile crisis + stabilization continuum
| Cell |
Score |
Basis |
Flag |
| 5A |
4 |
ws04: answered network contacts (ex-VCL) 161,267 Jan 2022 → 403,544 Jan 2024 (~2.5×); GAO-26-108114 ~19.1M contacts routed Jul 2022–Sep 2025, calls +87%, overall ~+90%; national answer rate 70% (May 2022) → 89% (May 2024), wait 2:20 → 1:31. This is measured improvement in crisis connection, which O1 explicitly admits. Not 5: operational before/after series with no counterfactual design, Lifeline covers ~200 of ~544 crisis centers, and ws04 warns answer-rate gains measure contact-center throughput. Also Swanson (MI) mobile-crisis response as the field-response leg. |
evidenced |
| 5B |
4 |
ws04/ws07: Kalb et al. Health Serv Res 2025 — each additional zip-level walk-in behavioural health crisis centre associated with ~2.8% lower mean mental/behavioural-disorder ED utilisation; Swanson et al. Michigan multi-site mobile crisis (IPTW) — ~45% lower 11-month arrest incidence vs law-enforcement-only. Both single-jurisdiction/associational → 4, not 5. I honoured ws04's instruction to keep 988 volume separate from diversion: the 988-specific diversion claim is unproven, and absence of a multi-state 988 causal estimate is not scored as failure. |
evidenced |
| 5C |
3 |
No finding on crisis-workforce payer participation or safety-net staffing response. |
unevidenced-neutral |
| 5D |
3 |
No OOP/parity finding for crisis services. |
unevidenced-neutral |
| 5E |
4 |
GAO-26-108114 + Vibrant KPIs: SAMHSA/administrator + state centres have run 988 routing continuously Jul 2022–Sep 2025 with published delivery metrics (~76% local answer for calls); Arizona comprehensive crisis system as a state-run continuum instance. Held at 4 not 5 because the row is continuum completion — the stabilization/mobile tier is not demonstrated at national scale — and GAO notes state-vs-administrator metric divergence and unmet text/chat local-answer goals. |
judgment-call |
a6 — Parity enforcement with ERISA teeth
| Cell |
Score |
Basis |
Flag |
| 6A |
3 |
Both directions, neither on appointment access: (+) EBSA corrections since Feb 2021 removed exclusions and fixed network-monitoring practices benefiting >7.6M participants in >72k plans (2024 MHPAEA RTC); NY 11 NYCRR 38 sets numeric behavioural wait/network standards; (−) comparative analyses were effectively all insufficient on initial submission (2022/2023 RTCs) and GAO-22-104597 documents continuing access challenges. Under KC1 there is no realized-access series to test against. |
evidenced-wash |
| 6B |
3 |
No acute/crisis capacity finding for parity enforcement. Wit is confined to holdings and is class-procedure/plan-interpretation, not capacity. |
unevidenced-neutral |
| 6C |
3 |
"Fixed network-monitoring practices" is a compliance action, not a measured change in clinicians accepting commercial coverage. No finding. |
unevidenced-neutral |
| 6D |
4 |
ws06: post-CAA-2021 federal comparative-analysis program produced final noncompliance determinations and corrections (exclusion removals, network-monitoring fixes) across >72k plans / >7.6M participants, including self-funded plans (FY2023 EBSA/CMS fact sheet cites self-funded plans with MH/SUD out-of-network use far above M/S); plus independent state exam root (MA c.26 §8K, 21 carriers; NY §343 biennial reports) finding fully insured gaps. Capped at 4 per KC3: EBSA reach is investigative spot-check, not census (2.6M plans / ~136M participants; DOL OIG 09-25-001: <1 investigator per ~16,472 plans), and the May 2025 statement non-enforces the new 2024-rule provisions. |
evidenced |
| 6E |
3 |
Both directions: (+) EBSA has actually operated the CAA comparative-analysis program at scale and MA/NY show state exam machinery working on fully insured plans; (−) DOL OIG 09-25-001 documents investigator capacity far below the plan universe and loss of supplemental NQTL funding; GAO-23-105642 notes no federal numeric network-adequacy standard; May 2025 non-enforcement of the 2024 rule. The census-style reach the row's spec assumes exceeds demonstrated capacity. |
evidenced-wash |
a7 — Assisted outpatient treatment
| Cell |
Score |
Basis |
Flag |
| 7A |
3 |
The NY/CA evaluations measure hospitalization, homelessness and arrest — not appointment offer, wait-to-evaluation, or crisis connection. ws07 notes service intensification (ICM/ACT) accompanies orders, but presents that as a confound, not a measured access outcome. There is also no evidence bearing on population outpatient access (the row spec's own warning). |
evidenced-wash (I considered 4 on the intensification reading and rejected it as mechanism) |
| 7B |
4 |
ws07: Swartz et al. Psychiatric Services 2010 (NYS OMH + Medicaid claims linkage, 3,576 AOT consumers 1999–2007): initial 6-month order → hospital admission OR 0.77, renewal → OR 0.59, hospital-days odds ~0.80–0.84; Laura's Law DHCS county-reported drops in hospitalization/LE contact among enrollees corroborate direction. ws07 calls this "the best domestic identification stack" and rates confidence "strong on … NY AOT administrative evaluations." Selection discipline applied: this is a selected-SMI band (prior hospitalization/non-adherence criteria), pre/post, with regression-to-mean and co-delivered ACT as live confounds — which is why it is 4 and not 5, and why it does not travel to population acute capacity. |
evidenced (with selection caveat) |
| 7C |
3 |
No finding on payer participation. |
unevidenced-neutral |
| 7D |
3 |
No OOP/parity finding. |
unevidenced-neutral |
| 7E |
4 |
NY OMH has operated Kendra's Law since 1999 with statewide administrative/Medicaid-linked reporting; CA DHCS produces legislative reports on Laura's Law. Held at 4 not 5 because ws07 documents county opt-out and reporting inconsistency in CA, so the class is not uniformly operated with measured delivery. |
judgment-call |
a8 — Collaborative Care / primary-care integration
| Cell |
Score |
Basis |
Flag |
| 8A |
3 |
This evidence base contains no CoCM or integration outcome evaluation at all — no IMPACT-class trial, no wait or appointment effect. ws05's only material on architecture #8 is NACHC on financing barriers (same-day billing bans, inadequate team-based BH reimbursement, documentation burden), which documents adoption friction, not that adoption fails to improve access. Floor applies upward: I did not credit the mechanism. |
unevidenced-neutral |
| 8B |
3 |
No finding. |
unevidenced-neutral |
| 8C |
3 |
NACHC describes health centres as "a major BH delivery surface" — a scale descriptor, not an effect. Per discipline 2 that does not lift the cell. |
unevidenced-neutral |
| 8D |
3 |
No finding. |
unevidenced-neutral |
| 8E |
3 |
Both directions: (+) CHCs deliver BH at material scale with >60 dual CHC–CCBHC certifications and telehealth/CMHC partnerships; (−) ws05's explicit scorecard guidance is that #8 "hits same-day billing and team payment as state-level binders," i.e. some states' Medicaid rules currently prevent billing the integrated encounter. Nets to mixed. |
evidenced-wash (I was genuinely torn between 3 and 4 here) |
a9 — Workforce liberalization
| Cell |
Score |
Basis |
Flag |
| 9A |
2 |
ws02 documents failure of the exact causal channel this instrument relies on: licensed/directory supply does not become usable access. Bishop JAMA Psychiatry 2014 — psychiatrists' Medicaid acceptance 43.1% while licensed supply exists; Brahmbhatt & Schpero JAMA 2024 — only 17.8% of directory-listed Medicaid prescribing clinicians in 4 cities were reachable, accepting and offering an appointment; Zhu Health Affairs 2022 — 58.2% of Oregon Medicaid directory listings phantom (67.4% MH prescribers); HRSA MH HPSA designated population rose 122M → 137M → 157.1M with no corresponding realized-access movement, and ws02 rules HPSA counts "licensed/assigned supply geography, not payer acceptance." ws02's Implications for scorecard instructs directly: "Architectures that only grow licensed headcount without rate/network/directory integrity score poorly on O1/O3" — honoured per discipline 6. |
evidenced, with disclosure: no compact / supervision-ratio / peer-billing instrument is itself evaluated anywhere in this base, and the peer-specialist-Medicaid-billing sub-instrument is a payer-participation lever the headcount critique does not reach. A scorer who treats the ws02 finding as mediating-channel evidence rather than instrument evidence would put this at 3. |
| 9B |
3 |
No finding on crisis/acute capacity from workforce liberalization. |
unevidenced-neutral |
| 9C |
2 |
Same citations as 9A; O3 is the axis ws02's instruction names explicitly. Bishop is the record's "existence proof that payer participation can dominate headcount" (ws02 §3 baseline non-substitution #2). |
evidenced (same disclosure as 9A) |
| 9D |
3 |
No finding. |
unevidenced-neutral |
| 9E |
3 |
Nothing in the record on compact commissions, state licensing-board capacity, or peer-certification machinery. |
unevidenced-neutral |
a10 — Do-nothing comparator
| Cell |
Score |
Basis |
Flag |
| 10A |
3 |
Split, and I am reporting the split rather than resolving it: (−) on outpatient, the status quo's measured proxies are static-poor — Brahmbhatt 17.8% usable access with median waits to 64 days (LA, IQR to 126), Bishop 43.1%, Oregon phantom rates, ~48% of AMI untreated; (+) on crisis, the current 988 funding path is exactly where the measured connection gains happened (answer rate 70% → 89%, wait 2:20 → 1:31, ~+90% routed contacts). O1 covers appointment or crisis response, so these net. |
evidenced-wash |
| 10B |
2 |
Cited evidence the status quo does not relieve measured contemporary acute stress: NRI 2025 — 90% of responding states report inpatient psych bed shortage (37 forensic, 38 non-state); TAC 2023 Construct A 10.8/100k with 52% forensic occupancy; McBain — Construct B flat 28.1 → 28.4/100k while STACH psych-unit share fell 24.9% → 20.6% and 846 counties (~244M residents) saw IPB rate declines; Pearlmutter multi-site boarding with Medicaid/uninsured >2× odds of ≥24h ED stay; patchwork IMD waivers leave adult IMD purchase barred by default outside ~15 states. Not 1 because the national contemporary bed rate is stable, not declining. |
evidenced |
| 10C |
2 |
Bishop 43.1% Medicaid acceptance (vs 73.0% other physicians), Brahmbhatt 17.8% usable, Zhu phantom 58.2%/67.4% — panels are documented as not open under the status quo, on two independent methods (ws02 H2 Supported). |
evidenced |
| 10D |
2 |
ws06 states it directly: "Do-nothing / parity-on-paper (architecture #10) fails H6's evidence bar." Supporting: 2022/2023 RTCs found reviewed comparative analyses insufficient on initial submission; FY2023 enforcement continues to find network-composition and exclusion NQTL problems; KC3 fires — state exams cannot reach the self-funded ERISA majority, and there is no federal numeric network-adequacy standard (GAO-23-105642). |
evidenced |
| 10E |
4 |
No incremental machinery, and the constituent instruments are demonstrably operating: GAO-26-108114 (~19.1M 988 contacts routed over 39 months), CRS IF10222 (approved MH IMD waivers in ~15 states + DC), EBSA operating MHPAEA jurisdiction over ~2.6M plans / ~136M participants with corrections since Feb 2021. Per discipline 5 I applied no comparator penalty, and this is the honest consequence of the O5 axis: doing nothing scores well on "can the agency run it." |
evidenced (and flagged as an axis artifact, not a merit finding) |
3. What my matrix implies
On my numbers the board is mostly flat, and the flatness is the finding: 32 of 50 cells sit at 3, and 15 of those are unevidenced-neutral. a2_ccbhc_expansion and a5_crisis_continuum tie as strongest — they are the only rows with cited positive effect evidence on two or more substantive axes (CCBHC: measured wait-to-evaluation and client-volume gains under Medicaid; crisis continuum: measured crisis connection plus two independent continuum studies on ED use and arrests). a9_workforce_liberalization and a10_do_nothing tie as weakest, for opposite reasons: a9 because the record documents failure of the licensure→usable-access channel it depends on, a10 because the record documents unrelieved acute stress, closed panels and unclosed parity gaps on the status-quo trajectory. a3_imd_repeal_waiver and a4_bed_rebuild come out numerically identical (3,3,3,3,4) — I am saying that plainly: the evidence base gives one a documentary financing constraint offset by a bed-count null, and the other essentially nothing but need documentation, and both land on the neutral floor. a1 and a7 sit mid-board with two evidenced cells each; a6 is single-cell evidenced (O4) and constrained by KC3; a8 is the only row with zero evidenced non-neutral cells.
4. Evidence-coverage count
| Architecture |
Cells scored off 3 on cited evidence |
Cells held at 3 as evidenced-wash |
Cells held at 3 as unevidenced-neutral |
| a1_medicaid_rate_floor |
2 (O3, O5) |
1 (O1) |
2 |
| a2_ccbhc_expansion |
3 (O1, O3, O5) |
1 (O2) |
1 |
| a3_imd_repeal_waiver |
1 (O5) |
1 (O2) |
3 |
| a4_bed_rebuild |
1 (O5) |
0 |
4 |
| a5_crisis_continuum |
3 (O1, O2, O5) |
0 |
2 |
| a6_parity_erisa |
1 (O4) |
2 (O1, O5) |
2 |
| a7_aot_expansion |
2 (O2, O5) |
1 (O1) |
2 |
| a8_collaborative_care |
0 |
1 (O5) |
4 |
| a9_workforce_liberalization |
2 (O1, O3) |
0 |
3 |
| a10_do_nothing |
4 (O2, O3, O4, O5) |
1 (O1) |
0 |
Total: 18 cells scored on cited evidence, 8 evidenced-wash, 24 unevidenced-neutral (one row, a2, has its 3s split 1/1).
5. What I could not score, and what would change my mind
Structurally unscoreable in this base:
- O4 for every row except a6 and a10. The record has one parity/financial-protection evidence stack (MHPAEA enforcement + state exams + KC3), and it touches only the parity architectures. Nothing in ws01–ws08 measures OOP exposure for Medicaid, CCBHC, crisis, AOT, bed, CoCM or workforce instruments. Eight O4 cells are pure floor.
- O3 for everything except a1, a2, a9, a10. The workforce-participation evidence (Bishop / Brahmbhatt / Zhu) is diagnostic of the problem, not of any instrument's effect on it, except where a rate/PPS design was actually evaluated.
- a8 entirely. There is no CoCM evaluation, no CoCM billing-code uptake data, and no integration outcome anywhere in this base — only NACHC financing-barrier statements. If someone scores a8 above 3 on O1, they are scoring the general CoCM literature, which is not in this evidence base.
- a4's core claim (O2). The whole rationale for bed reinvestment — that added acute/forensic capacity relieves boarding and admit constraints — has no cited instrument evaluation here. KC2 removed the historical baseline; nothing replaced it with a contemporary reinvestment evaluation.
- Realized access under commercial coverage anywhere. KC1 plus KC3: Brahmbhatt has no commercial arm, no by-payer wait series exists, and the self-funded majority is band-only. Every commercial O1 judgment in this board is proxy-free.
What would move specific cells:
- 1A/1C → 4/5: a rate-change design with an appointment-offer or wait outcome, or evidence of new panel openings at post-change rates near 90–100% of Medicare (ws05 hints the elasticity is concentrated there but does not measure panel entry).
- 2B → 4: a multi-state CCBHC ED/hospitalization DID that is not heterogeneous, or a crisis-throughput measure tied to the required crisis criterion.
- 3B → 4 or 2: a waiver-vs-non-waiver boarding or admit-financing evaluation. ws03 explicitly logs this comparison pair as not located; it is the single highest-value missing study on this board.
- 4B → 4: any evaluation of a state acute/forensic reinvestment program on contemporary constructs (Construct A or B) with a boarding or admit outcome.
- 5B → 5: a multi-state causal 988→ED/arrest diversion estimate surviving an independence audit. ws04 flags this as absent but plausible in future; its arrival would also raise 5A.
- 6D → 5, or 6E → 4: evidence of census-style federal reach into self-funded plans (KC3 explicitly bars 5 without it), or restored NQTL investigator funding plus resolution of the May 2025 non-enforcement posture.
- 7A/7B → down: a comparison-group AOT design separating court leverage from the ACT/ICM package. The current 4 on 7B rests on pre/post in a selected cohort and would not survive a well-identified null.
- 9A/9C → 3: any evaluation of an interstate compact, a supervision-ratio change, or peer-specialist Medicaid billing showing a payer-participation or appointment effect. These are the two cells on this board most likely to be scored differently by a co-scorer, because they rest on the record's instruction about headcount architectures plus channel-level evidence, rather than on an evaluation of the instrument itself. I flag that as my largest disclosed judgment call.
One anchor-fit complaint. O5's anchors reward instruments that are already running, which mechanically advantages the do-nothing comparator (10E = 4) and disadvantages nothing except genuinely novel machinery. I applied the anchors as written rather than adjusting, but the resulting O5 column is nearly constant (nine 4s and one 3 out of ten... in fact seven 4s and three 3s) and carries little discriminating information on this board.